Abiopharma

Pacira BioSciences Enters Exclusive License Agreement with AmacaThera for its Novel Long-acting Analgesic for Postsurgical Pain Control

Zoetis Announces Third Quarter 2025 Results

Compugen to Participate in Stifel 2025 Healthcare Conference

BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)

Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody

Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance

SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance

Kura Oncology Reports Third Quarter 2025 Financial Results

Premier, Inc. Reports Fiscal-Year 2026 First-Quarter Financial Results